Crinetics Pharmaceuticals ROA - Return on Assets 2017-2024 | CRNX

Crinetics Pharmaceuticals return on assets for the quarter ending September 30, 2024 was -31.9.

  • Crinetics Pharmaceuticals average return on assets for 2023 was -49.36, a 16.94% decline from 2022.
  • Crinetics Pharmaceuticals average return on assets for 2022 was -42.21, a 8.79% increase from 2021.
  • Crinetics Pharmaceuticals average return on assets for 2021 was -46.28, a 14.22% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

Crinetics Pharmaceuticals ROA - Return on Assets 2017-2024 | CRNX

  • Crinetics Pharmaceuticals average return on assets for 2023 was -49.36, a 16.94% decline from 2022.
  • Crinetics Pharmaceuticals average return on assets for 2022 was -42.21, a 8.79% increase from 2021.
  • Crinetics Pharmaceuticals average return on assets for 2021 was -46.28, a 14.22% decline from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.